We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Well-Timed Referral Needed for Intestinal Transplant

By HospiMedica staff writers
Posted on 02 Aug 2006
Timely referral for intestinal transplantation--a life-saving procedure for patients with irreversible intestinal failure--can reduce mortality rates, according to a new study.

Researchers from nine European countries investigated patient candidacy and physician attitudes toward intestinal transplantation (ITx) among centers that participated in previous European surveys on home parenteral nutrition (HPN). More...
The patients on HPN for benign intestinal failure (IF) were evaluated by a structured questionnaire. Candidacy was assessed by the U.S. Medicare and American Transplantation Society (ATS) criteria, and categorized as one of the following: (1) life-threatening HPN complications, (2) high risk of death because of gastrointestinal disease, (3) IF with high morbidity or patient HPN refusal. Physicians judged candidacy as immediate or potential.

Forty-one centers from nine countries enrolled 688 adults and 166 pediatric patients; 70% of patients were from five countries that collected 60-100% of their HPN patients. Candidacy was 15.7% in adults and 34.3% in pediatrics. Immediate candidacy was required for 14.8% of adult and 15.8% of pediatric candidates (less than 50% of the candidates because of HPN-related liver failure). Among the major contributing countries, candidacy ranged 0.3-0.8 per million inhabitants for adults and 0.9-2 per million inhabitants for pediatric (under 18 years old) candidates. The rate of candidacy and the indications for ITx candidacy differed greatly among age groups and HPN centers, but within countries candidacy was more homogeneous. Physicians had a generally reserved attitude toward ITx. The results were published in the July 2006 issue of the American Journal of Gastroenterology

"Irreversible intestinal failure is a condition which has a deep impact on the patient's health and quality of life; it requires great organizational and economical efforts by the national health care system and professionals,” said lead author Dr. Loris Pironi, an associate professor of internal medicine at the University of Bologna (Italy).

Knowing the criteria for which transplantation may be necessary will enable doctors to refer patients when needed. Patient referrals for transplantation may come too late, and this may increase mortality rates among those on the waiting list.



Related Links:
University of Bologna

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Vessel Sealing Instrument
ERGOseal
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.